General Announcement::Announcement by TMC Life Sciences Bhd, 3Q FY2023 results for the period ended 31 March 2023

Issuer & Securities

Issuer/ Manager
THOMSON MEDICAL GROUP LIMITED
Securities
THOMSON MED S$175M4.05%N250128 - SGXF89249654 - RMEB
THOMSON MEDICAL GROUP LIMITED - SG1M49904634 - A50
Stapled Security
No

Announcement Details

Announcement Title
General Announcement
Date &Time of Broadcast
23-May-2023 19:47:23
Status
New
Announcement Sub Title
Announcement by TMC Life Sciences Bhd, 3Q FY2023 results for the period ended 31 March 2023
Announcement Reference
SG230523OTHRW5J1
Submitted By (Co./ Ind. Name)
Dr Melvin Heng Jun Li
Designation
Executive Director and Group CEO
Description (Please provide a detailed description of the event in the box below)
Pls refer to the attached.

Attachments

TMCLS Announcement_Q3 2023-Final.pdf
Total size =273K